Adjuvant Tamoxifen for male breast cancer (MBC) (Q35993992)

11 August 2017

Adjuvant Tamoxifen for male breast cancer (MBC) (English)

1 reference

13 November 2022

1 reference

1 reference

13 November 2022

1 reference

G. Ribeiro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739625

13 November 2022

R. Swindell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739625

13 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

PMCID

1977740

full work available at URL

11 August 2017

https://europepmc.org/articles/PMC1977740

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739625

https://europepmc.org/articles/PMC1977740?pdf=render

13 November 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739625

http://www.nature.com/articles/bjc199250.pdf

13 November 2022

file format

Portable Document Format

1 reference

http://www.nature.com/articles/bjc199250

13 November 2022

1 reference

British Journal of Cancer

13 November 2022

published in

1 reference

11 August 2017

65

1 reference

11 August 2017

2

1 reference

11 August 2017

252-254

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1992.50

11 August 2017

0 references

cites work

Serum oestradiol-17 beta, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977740

Male breast cancer. 5. Clinical manifestations in 257 cases in Denmark

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977740

Long-term survival in 406 males with breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977740

Male breast carcinoma--a review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977740

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977740

Changes in the pituitary-testicular system with age.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977740

Male breast cancer.A natural history study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977740

Adjuvant chemotherapy in males with cancer of the breast

11 July 2018

1 reference

PubMed

12 December 2020

Tamoxifen in the treatment of male breast carcinoma

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Two methods for measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response treatment

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.1038/BJC.1992.50

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

PMCID

1977740